CAS 1610537-15-9

Seviteronel

Description:

Seviteronel, with the CAS number 1610537-15-9, is a synthetic chemical compound primarily investigated for its potential therapeutic applications, particularly in the treatment of certain types of cancer and other diseases. It functions as a selective inhibitor of specific enzymes involved in steroidogenesis, which may influence hormone levels and related pathways. The compound is characterized by its unique molecular structure, which contributes to its biological activity and selectivity. Seviteronel has been studied for its pharmacokinetic properties, including absorption, distribution, metabolism, and excretion, which are crucial for determining its efficacy and safety profile in clinical settings. Additionally, ongoing research aims to elucidate its mechanism of action and potential side effects, as well as its interactions with other medications. As with many investigational drugs, the full spectrum of its characteristics, including optimal dosing and long-term effects, is still under evaluation in clinical trials.

Formula: C₁₈H₁₇F₄N₃O₃

InChI: InChI=1S/C18H17F4N3O3/c1-9(2)18(26,15-8-23-25-24-15)12-4-3-10-6-13(27-16(19)20)14(28-17(21)22)7-11(10)5-12/h3-9,16-17,26H,1-2H3,(H,23,24,25)/t18-/m0/s1

InChI key: InChIKey=ZBRAJOQFSNYJMF-SFHVURJKSA-N

SMILES: [C@](C(C)C)(O)(C1=CC2=C(C=C1)C=C(OC(F)F)C(OC(F)F)=C2)C3=CN=NN3

Synonyms:

• Seviteronel
• (αS)-α-[6,7-Bis(difluoromethoxy)-2-naphthalenyl]-α-(1-methylethyl)-1H-1,2,3-triazole-5-methanol
• (1S)-1-[6,7-Bis(difluoromethoxy)naphthalen-2-yl]-2-methyl-1-(2H-triazol-4-yl)propan-1-ol
• 1H-1,2,3-Triazole-5-methanol, α-[6,7-bis(difluoromethoxy)-2-naphthalenyl]-α-(1-methylethyl)-, (αS)-
• VT 464

1H-1,2,3-Triazole-5-methanol, α-[6,7-bis(difluoromethoxy)-2-naphthalenyl]-α-(1-methylethyl)-, (αS)-

CAS: 1610537-15-9

Formula: C₁₈H₁₇F₄N₃O₃

Purity: 95%

Molecular weight: 399.3395

Ref: IN-DA001VLJ

Seviteronel

CAS: 1610537-15-9

Seviteronel

Purity: ≥98%

Molecular weight: 399.34g/mol

Ref: 54-BUP08800

Seviteronel

CAS: 1610537-15-9

Seviteronel is a monoclonal antibody that binds to the epidermal growth factor receptor (EGFR), which is a protein involved in cell signaling and proliferation. Seviteronel has been shown to be effective against breast cancer, prostate cancer, and malignant brain tumors. It has also shown significant cytotoxicity in vitro assays. When grafted onto a carrier molecule, seviteronel has been shown to bind to the EGFR on the surface of cancer cells, inhibiting their growth.

Formula: C₁₈H₁₇F₄N₃O₃

Purity: Min. 95%

Molecular weight: 399.34 g/mol

Ref: 3D-KPC53715

Seviteronel

CAS: 1610537-15-9

Seviteronel (VT-464) is a novel CYP17 cleavage enzyme inhibitor and androgen receptor antagonist for the study of breast and prostate cancer.

Formula: C₁₈H₁₇F₄N₃O₃

Purity: 99.67% - 99.98%

Color and Shape: Solid

Molecular weight: 399.34

Ref: TM-T13312L